Best adjuvant (assist) for chemotherapy | 1+1>487% |
Effectively improve chemotherapy effect, treatment, immunity |
Reduce side effects and recurrence |
Overview / Relation / Abstract / Role / Principle / Action / Mechanism / Function / Work |
Abstract / Summary / Overview of Apoptosis
Why do cells undergo apoptosis?
The relationship between cancer cells and apoptosis
Where are the weaknesses and symptoms of cancer cells?
Are cancer cells aggressive?
Extraordinary Solamargine (Role, Principle, Action, Mechanism, Function, Work)
Solamargine's major function mechanism:
Solamargine vs cancer
Best Chemotherapy Adjuvant (1+1>478%) Effectively improve chemotherapy effect and cure
Best adjuvant (assist) for chemotherapy | 1+1>487%
Effectively improve chemotherapy effect, treatment, immunity
Reduce side effects and recurrence
Overview / Relation / Abstract / Role / Principle / Action / Mechanism / Function / Work
Abstract / Summary / Overview of Apoptosis
Overview of apoptosis
•Programmed cell death
•Apoptosis is a form of programmed cell death, or “cellular suicide.”
•Apoptosis is different from necrosis, in which cells die due to injury.
•Apoptosis removes cells during development, eliminates potentially cancerous and virus-infected cells, and maintains balance in the body.
Why do cells undergo apoptosis?
- Basically, apoptosis is a general and convenient way to remove cells that should no longer be part of the organism.
- Some cells are abnormal and could hurt the rest of the organism if they survive, such as cells with viral infections or DNA damage.
- Apoptosis is part of development
- In many organisms, programmed cell death is a normal part of development.
The relationship between cancer cells and apoptosis
Apoptosis can eliminate infected or cancerous cells.
When a cell’s DNA is damaged, it will typically detect the damage and try to repair it.
If the damage is beyond repair, the cell will normally send itself into apoptosis, ensuring that it will not pass on its damaged DNA.
When cells have DNA damage but fail to undergo apoptosis, they may be on the road to cancer.
However, “successful” cancer cells successfully evade the process of apoptosis.
This allows them to divide out of control and accumulate mutations (changes in their DNA).
Apoptosis is key to immune function
Apoptosis also plays an essential role in the development and maintenance of a healthy immune system.
Where are the weaknesses and symptoms of cancer cells?
The symptoms of cancer cells are in the nucleus.
The nucleus controls the outer cytoplasm, cell composition, cell viability, etc.
DNA mutations also mutate in the nucleus.
Therefore, to treat cancer cells, we must first enter the nucleus.
Let the “regulatory cell gene” mechanism enter the nucleus to regulate
Are cancer cells aggressive?
After the action of Solamargine, the aggressiveness of cancer cells is alleviated.
So after using Solamargine, many patients feel that I am half better.
Although the tumor does not disappear quickly, patients feel that the degree of aggressiveness is reduced.
Extraordinary Solamargine (Role, Principle, Action, Mechanism, Function, Work)
Solamargine's major function mechanism:
When Solamargine enter,
Solamargine activates receptors that are turned off by cancer cells, allowing cancer cells to modulate again.
Solamargine modulates the anti-modulates genes of cancer cells, making cancer cells less resistant.
Reduced drug resistance
When cancer cells are less resistant to drugs, chemotherapy becomes more effective.
Solamargine modulates the mutated genes in cancer cells and then initiates cancer cell apoptosis to achieve anti-cancer effects.
Solamargine combined with which chemotherapy drugs are more effective in treating cancer cells?
Solamargine vs cancer
Solamargine vs cancer
The picture shows the death of cancer cells.
The black and black parts are cancer cell nuclei.
Even if the nucleus ruptures, the cancer cells will die.
The figure shows that cancer cells can cause death.
The figure shows that cancer cells can cause death.
The figure shows that the death of lung cancer cells is relatively slow, and it will not be obvious until eight hours later.
The figure shows that the death of liver cancer cells is very obvious, even more obvious in eight hours.
The graph shows that breast cancer cells die faster. It was obvious from the beginning that breast cancer is easy to treat, and patients with breast cancer need not worry.
Best Chemotherapy Adjuvant (1+1>487%) Effectively improve chemotherapy effect and treatment
ANTI-CANCER
Patent protection in 32 nations.
A comparison study showing Solamargine vs. other therapeutic drugs with respect to lung cancer cells.
A comparison study showing Solamargine vs. other chemotherapeutic drugs with respect to breast cancer cells
SR-T100 combination therapy with effective result against breast cancer cells.
Combination Therapy | Research results for lung cancer cells.
A. Chemotherapy (100μM), 16% of cancer cell apoptosis.
B. Alone SM (4.8μM), 28% of cancer cell apoptosis.
C. SM (4.80μM) + Chemotherapy (40μM), 66% of cancer cells apoptosis.
D. SM (4.80μM) + Chemotherapy (100μM), 78% of cancer cell apoptosis.
SM has a clearing effect better than Chemotherapy.
The combined treatment of Solamargine and Chemotherapy significantly increased the apoptosis of lung cancer cells.
SM (4.8μM) + Chemotherapy (40μM), increased from 16% to 66% (up to 4.125 times).
SM (4.8μM) + Chemotherapy (100μM), increased from 16% to 78% (up to 4.875 times)
Reorganized from: BBRC. Action of Solamargine on TNFs and drug-resistant human lung cancer cells 2004
Solamargine Q&A (English)
survival rate | cancer | Contents
survival rate | cancer | Etymology and definitions
survival rate | cancer | Signs and symptoms
survival rate | cancer | Local symptoms
survival rate | cancer | Systemic symptoms
survival rate | cancer | Metastasis
survival rate | cancer | Causes
survival rate | cancer | Chemicals
survival rate | cancer | Diet and exercise
survival rate | cancer | Infection
survival rate | cancer | Radiation
survival rate | cancer | Heredity
survival rate | cancer | Physical agents
survival rate | cancer | Hormones
survival rate | cancer | Autoimmune diseases
survival rate | cancer | Pathophysiology
survival rate | cancer | Genetics
survival rate | cancer | Epigenetics
survival rate | cancer | Metastasis
survival rate | cancer | Metabolism
survival rate | cancer | Diagnosis
survival rate | cancer | Classification
survival rate | cancer | Prevention
survival rate | cancer | Dietary
survival rate | cancer | Medication
survival rate | cancer | Vaccination
survival rate | cancer | Screening
survival rate | cancer | Recommendations
survival rate | cancer | Genetic testing
survival rate | cancer | Management
survival rate | cancer | Cancer
survival rate | cancer | Radiation
survival rate | cancer | Surgery
survival rate | cancer | Palliative care
survival rate | cancer | Immunotherapy
survival rate | cancer | Laser therapy
survival rate | cancer | Alternative medicine
survival rate | cancer | Prognosis
survival rate | cancer | Epidemiology
survival rate | cancer | History
survival rate | cancer | Society and culture
survival rate | cancer | Economic effect
survival rate | cancer | Workplace
survival rate | cancer | Research
survival rate | cancer | Pregnancy
survival rate | cancer | Other animals
survival rate | cancer | Notes
survival rate | cancer | Further reading
survival rate | cancer | External links
Плоскоклеточный рак | SCC | Эпидермоидная карцинома | выживаемости | Contents
Плоскоклеточный рак | SCC | Эпидермоидная карцинома | выживаемости | Etymology and definitions
Плоскоклеточный рак | SCC | Эпидермоидная карцинома | выживаемости | Signs and symptoms
Плоскоклеточный рак | SCC | Эпидермоидная карцинома | выживаемости | Local symptoms
Плоскоклеточный рак | SCC | Эпидермоидная карцинома | выживаемости | Systemic symptoms
Плоскоклеточный рак | SCC | Эпидермоидная карцинома | выживаемости | Metastasis
Плоскоклеточный рак | SCC | Эпидермоидная карцинома | выживаемости | Causes
Плоскоклеточный рак | SCC | Эпидермоидная карцинома | выживаемости | Chemicals
Плоскоклеточный рак | SCC | Эпидермоидная карцинома | выживаемости | Diet and exercise
Плоскоклеточный рак | SCC | Эпидермоидная карцинома | выживаемости | Infection
Плоскоклеточный рак | SCC | Эпидермоидная карцинома | выживаемости | Radiation
Плоскоклеточный рак | SCC | Эпидермоидная карцинома | выживаемости | Heredity
Плоскоклеточный рак | SCC | Эпидермоидная карцинома | выживаемости | Physical agents
Плоскоклеточный рак | SCC | Эпидермоидная карцинома | выживаемости | Hormones
Плоскоклеточный рак | SCC | Эпидермоидная карцинома | выживаемости | Autoimmune diseases
Плоскоклеточный рак | SCC | Эпидермоидная карцинома | выживаемости | Pathophysiology
Плоскоклеточный рак | SCC | Эпидермоидная карцинома | выживаемости | Genetics
Плоскоклеточный рак | SCC | Эпидермоидная карцинома | выживаемости | Epigenetics
Плоскоклеточный рак | SCC | Эпидермоидная карцинома | выживаемости | Metastasis
Плоскоклеточный рак | SCC | Эпидермоидная карцинома | выживаемости | Metabolism
Плоскоклеточный рак | SCC | Эпидермоидная карцинома | выживаемости | Diagnosis
Плоскоклеточный рак | SCC | Эпидермоидная карцинома | выживаемости | Classification
Плоскоклеточный рак | SCC | Эпидермоидная карцинома | выживаемости | Prevention
Плоскоклеточный рак | SCC | Эпидермоидная карцинома | выживаемости | Dietary
Плоскоклеточный рак | SCC | Эпидермоидная карцинома | выживаемости | Medication
Плоскоклеточный рак | SCC | Эпидермоидная карцинома | выживаемости | Vaccination
Плоскоклеточный рак | SCC | Эпидермоидная карцинома | выживаемости | Screening
Плоскоклеточный рак | SCC | Эпидермоидная карцинома | выживаемости | Recommendations
Плоскоклеточный рак | SCC | Эпидермоидная карцинома | выживаемости | Genetic testing
Плоскоклеточный рак | SCC | Эпидермоидная карцинома | выживаемости | Management
Плоскоклеточный рак | SCC | Эпидермоидная карцинома | выживаемости | Chemotherapy
Плоскоклеточный рак | SCC | Эпидермоидная карцинома | выживаемости | Radiation
Плоскоклеточный рак | SCC | Эпидермоидная карцинома | выживаемости | Surgery
Плоскоклеточный рак | SCC | Эпидермоидная карцинома | выживаемости | Palliative care
Плоскоклеточный рак | SCC | Эпидермоидная карцинома | выживаемости | Immunotherapy
Плоскоклеточный рак | SCC | Эпидермоидная карцинома | выживаемости | Laser therapy
Плоскоклеточный рак | SCC | Эпидермоидная карцинома | выживаемости | Alternative medicine
Плоскоклеточный рак | SCC | Эпидермоидная карцинома | выживаемости | Prognosis
Плоскоклеточный рак | SCC | Эпидермоидная карцинома | выживаемости | Epidemiology
Плоскоклеточный рак | SCC | Эпидермоидная карцинома | выживаемости | History
Плоскоклеточный рак | SCC | Эпидермоидная карцинома | выживаемости | Society and culture
Плоскоклеточный рак | SCC | Эпидермоидная карцинома | выживаемости | Economic effect
Плоскоклеточный рак | SCC | Эпидермоидная карцинома | выживаемости | Workplace
Плоскоклеточный рак | SCC | Эпидермоидная карцинома | выживаемости | Research
Плоскоклеточный рак | SCC | Эпидермоидная карцинома | выживаемости | Pregnancy
Плоскоклеточный рак | SCC | Эпидермоидная карцинома | выживаемости | Other animals
Плоскоклеточный рак | SCC | Эпидермоидная карцинома | выживаемости | Notes
Плоскоклеточный рак | SCC | Эпидермоидная карцинома | выживаемости | Further reading
Плоскоклеточный рак | SCC | Эпидермоидная карцинома | выживаемости | External links